Prof. Hanna Rosenman

Hanna Rosenman

Prof. Hanna Rosenman

Laboratory of Experimental Neurology, Department of Neurology, Hadassah Hebrew University Medical Center; Neurobiology, The Hebrew University - Medical School, Jerusalem.
p: 0505172295

 

Research in my lab focuses on therapies for Alzheimer's disease (AD) and other dementias (such as frontotemporal dementia). For this purpose we generated novel mouse models, which mimic authentically the diseases in the dementia patients.  Using the animal models we are developing therapeutic approaches, at the cutting edge of the AD research. This includes:

1.Developing a vaccine which clears the brain of dementia patients from the toxic tau protein accumulation, and thereby stops the cognitive decline.

2.Developing the novel therapeutic approach of CSF Exchange Therapy, in which the endogenous pathogenic CSF is exchanged with lively bioactive fluid (like by artificial CSF enriched by secretions of mesenchymal stem cells) in system.

3.Developing Mitochondrial Transfer Therapy for dementia diseases.

4.Neurogenetic aspects of neurodegenerative diseases.

5.Identifying dementia protective properties among existing drugs (in use in other diseases), and among herbal extracts (natural products), since such substances have the potential to become commercially available against dementia within a short time with low cost.